Bellevue, WA, United States of America

Robin Callan

This inventor holds 5 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignee: Advanced Renal Technologies. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robin Callan. Retrieved from https://idiyas.com/inventor/robin-callan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 161(Granted Patents)


Location History:

  • Bellevue, WA (US) (2003 - 2014)
  • Medina, WA (US) (2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Dialysis: The Contributions of Robin Callan

Introduction

Robin Callan is an accomplished inventor based in Bellevue, WA (US), known for his significant contributions to the field of dialysis. With a total of 5 patents to his name, Callan has focused on improving the efficacy and safety of dialysis treatments. His work has the potential to enhance the quality of life for patients undergoing hemodialysis.

Latest Patents

Among his latest patents, Callan has developed innovative buffered compositions for dialysis. One of his notable inventions is a dialysate composition that contains citric acid and a buffering agent selected from acetate and/or lactate. This formulation allows for a physiologically acceptable amount of citrate to maintain the desired pH of the dialysate. Another significant patent addresses the use of citrate-containing dialysate, which has shown superior performance properties compared to traditional acetic acid-based solutions. Clinical studies indicated that patients using this citrate dialysate experienced improved serum bicarbonate levels and enhanced urea clearance.

Career Highlights

Callan's career is marked by his dedication to advancing renal technologies. He is currently associated with Advanced Renal Technologies, where he continues to innovate in the field of dialysis. His research has led to breakthroughs that not only improve treatment outcomes but also contribute to a better understanding of the biochemical processes involved in dialysis.

Collaborations

Throughout his career, Callan has collaborated with esteemed colleagues, including James J. Cole and Walter A. Van Schalkwijk. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in renal care.

Conclusion

Robin Callan's contributions to dialysis technology exemplify the impact of innovation in healthcare. His patents and research efforts are paving the way for improved treatment options for patients, showcasing the importance of continued advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…